Minneapolis / St. Paul Business Journal by Mark Reilly, Managing Editor
St. Jude Medical Inc. said a new study of a implanted device helped ease migraines for patients.The Star Tribune reports on the study of 157 patients who regularly suffered from migraine headaches 21 days a month, on average. Patients using St. Jude’s Genesis neurostimulator reported an average of six fewer headaches a month. Little Canada-based St. Jude won approval to sell the device in Europe last year.
